Trial Innovation Network

The Translational Research Institute (TRI) is part of the national Trial Innovation Network. This is a new collaborative effort within the Clinical and Translational Science Award (CTSA) Program aimed at executing trials better, faster, and more cost-efficiently with an emphasis on being a national laboratory to study, understand and innovate the process of conducting clinical trials.

The vision for the Trial Innovation Network is to “innovatively address critical roadblocks in clinical trials and accelerate the translation of novel interventions into life-saving therapies.”

The Trial Innovation Network is seeking your proposals. Submit your proposal (requires filling out a brief registration form).

Learn more at the Trial Innovation Network website.

Program Leadership

Laura Hutchins
Laura Hutchins, MD
Greg Kearns
Greg Kearns, PhD, PharmD

TRI’s TIN Liaison Team

Laura Hutchins, MD Medical Co-Director – UAMS
Gregory Kearns, PharmD, PhD Medical Co-Director – ACH
Amy Jo Jenkins, MS TIN Point of Contact
Jennifer Holland, JD IRB Chair – UAMS
Sherry Courtney, MD* Lifespan Team – Neonatal Representative – UAMS/ACH
Jose Romero, MD* Lifespan Team – Pediatric Representative – UAMS/ACH
Luis Juncos, MD* Lifespan Team – Adult Representative – UAMS/CAVHS
Gohar Azhar, MD* Lifespan Team – Older Adult Representative- UAMS
Stacie Jones, MD Co-Director, Recruitment – ACH
Jean McSweeney, RN Co-Director, Recruitment – UAMS
Dori Scoggins, JD Federal Demonstration Partnership, CTSA Standard Agreements Contact
Cindy Witkowski, RN Team Member, Clinical Research, UAMS
Jonathan Young, MA Team Member, Research Administration, UAMS
Janet Storment, RN Team Member, Clinical Research & Administration – ACH